|Benefit-Cost Summary Statistics Per Participant|
|Taxpayers||$526||Benefits minus costs||$1,090|
|Participants||$939||Benefit to cost ratio||$2.66|
|Others||$325||Chance the program will produce|
|Indirect||($42)||benefits greater than the costs||61%|
|Net program cost||($657)|
|Benefits minus cost||$1,090|
|Meta-Analysis of Program Effects|
|Outcomes measured||Treatment age||No. of effect sizes||Treatment N||Adjusted effect sizes(ES) and standard errors(SE) used in the benefit - cost analysis||Unadjusted effect size (random effects model)|
|First time ES is estimated||Second time ES is estimated|
Loss or gain of total body weight
Diastolic blood pressure^
The blood pressure in the arteries when the heart rests between beats. This is the second (or bottom) number in a blood pressure reading.
Systolic blood pressure^
The blood pressure in the arteries when the heart beats. This is the first (or top) number in a blood pressure reading.
“Good cholesterol” that is associated with lower risk of cardiovascular disease.
“Bad cholesterol” that is associated with higher risk of cardiovascular disease.
Obese based on clinical guidelines for adults (body mass index of 30 or higher) or children (body mass index at or above the 95th percentile for children of the same age and sex), as appropriate.
|Detailed Monetary Benefit Estimates Per Participant|
|Affected outcome:||Resulting benefits:1||Benefits accrue to:|
|Obesity||Labor market earnings associated with obesity||$360||$845||$0||($180)||$1,025|
|Health care associated with obesity||$156||$70||$325||$78||$629|
|Mortality associated with obesity||$10||$23||$0||$389||$422|
|Program cost||Adjustment for deadweight cost of program||$0||$0||$0||($329)||($329)|
|Detailed Annual Cost Estimates Per Participant|
|Annual cost||Year dollars||Summary|
|Program costs||$313||2014||Present value of net program costs (in 2018 dollars)||($657)|
|Comparison costs||$0||2014||Cost range (+ or -)||25%|
Benefits Minus Costs
Benefits by Perspective
Taxpayer Benefits by Source of Value
|Benefits Minus Costs Over Time (Cumulative Discounted Dollars)|
|The graph above illustrates the estimated cumulative net benefits per-participant for the first fifty years beyond the initial investment in the program. We present these cash flows in discounted dollars. If the dollars are negative (bars below $0 line), the cumulative benefits do not outweigh the cost of the program up to that point in time. The program breaks even when the dollars reach $0. At this point, the total benefits to participants, taxpayers, and others, are equal to the cost of the program. If the dollars are above $0, the benefits of the program exceed the initial investment.|
Appel, L.J., Clark, J.M., Yeh, H.C., Wang, N.Y., Coughlin, J.W., Daumit, G., Miller, E.R., Dalcin, A., Jerome, G., Geller, S., Noronha, G., Pozefsky, T., Charleston, J., Reynolds., Durkin, N., Rubin, R., Louis, T.A., & Brancati, F.L. (2011). Comparative effectiveness of weight-loss interventions in clinical practice. The New England Journal of Medicine, 365(21), 1959-1968.
Burke, V., Beilin, L.J., Cutt, H.E., Mansour, J., Wilson, A., & Mori, T.A. (2005). Effects of a lifestyle programme on ambulatory blood pressure and drug dosage in treated hypertensive patients: a randomized controlled trial. Journal of Hypertension, 23(6), 1241-1249.
de Vos, B.C., Runhaar, J., & Bierma-Zeinstra, S.M. (2014). Effectiveness of a tailor-made weight loss intervention in primary care. European Journal of Nutrition, 53(1), 95-104.
Eriksson, M.K., Franks, P.W., & Eliasson, M. (2009). A 3-year randomized trial of lifestyle intervention for cardiovascular risk reduction in the primary care setting: the Swedish Björknäs study. Plos One, 4(4), e5195.
Fitzgibbon, M.L., Stolley, M.R., Schiffer, L., Sharp, L.K., Singh, V., & Dyer, A. (2010). Obesity reduction black intervention trial (ORBIT): 18-month results. Obesity, 18(12), 2317-2325.
Jeffery, R.W., Wing, R.R., Thorson, C., Burton, L.R., Raether, C., Harvey, J., & Mullen, M. (1993). Strengthening behavioral interventions for weight loss: a randomized trial of food provision and monetary incentives. Journal of Consulting and Clinical Psychology, 61(6), 1038-1045.
Kumanyika, S.K., Fassbender, J.E., Sarwer, D.B., Phipps, E., Allison, K.C., Localio, R., Morales, K.H., Wesby, L., Harralson, T., Kessler, R., Tan-Torres, S., Han, X., Tsai, A.G., & Wadden, T.A. (2012). One-year results of the Think Health! study of weight management in primary care practices.Obesity, 20(6), 1249-1257.
The Trials of Hypertension Collaborative Research Group (1997). Effects of Weight Loss and Sodium Reduction Intervention on Blood Pressure and Hypertension Incidence in Overweight People With High-Normal Blood Pressure. Archives of Internal Medicine, 157(6), 657-667.
Ross, R., Lam, M., Blair, S.N., Church, T.S., Godwin, M., Hotz, S.B., Johnson, A., Katzmarzyk, P.T., Levesque, L. & MacDonald, S. (2012). Trial of prevention and reduction of obesity through active living in clinical settings: a randomized controlled trial. Archives of Internal Medicine, 172(5), 414-424.
Silva, M.N., Vieira, P.N., Coutinho, S.R., Minderico, C.S., Matos, M.G., Sardinha, L.B., & Teixeira, P.J. (2010). Using self-determination theory to promote physical activity and weight control: a randomized controlled trial in women. Journal of Behavioral Medicine, 33(2), 110-122.
Vetter, M.L., Wadden, T.A., Chittams, J., Diewald, L.K., Panigrahi, E., Volger, S., Sarwer, D.B., & Moore, R.H.. (2013). Effect of lifestyle intervention on cardiometabolic risk factors: results of the POWER-UP trial. International Journal of Obesity, 37(1), 19-24.
Villareal, D.T., Shah, K., Banks, M.R., Sinacore, D.R., & Klein, S. (2008). Effect of weight loss and exercise therapy on bone metabolism and mass in obese older adults: a one-year randomized controlled trial. The Journal of Clinical Endocrinology and Metabolism, 93(6), 2181-2187.
Wadden, T.A., Volger, S., Sarwer, D.B., Vetter, M.L., Tsai, A.G., Berkowitz, R.I., Kumanyika, S., Schmitz, K.H., Diewald, L.K., Barg, R., Chittams, J., & Moore, R.H. (2011). A two-year randomized trial of obesity treatment in primary care practice. The New England Journal of Medicine, 365(21), 1969-1979.
Wood, P.D., Stefanick, M.L., Williams, P.T., & Haskell, W.L. (1991). The effects on plasma lipoproteins of a prudent weight-reducing diet, with or without exercise, in overweight men and women. The New England Journal of Medicine, 325(7), 461-466.
Woollard, J., Burke, V., Beilin, L.J., Verheijden, M., & Bulsara, M.K. (2003). Effects of a general practice-based intervention on diet, body mass index and blood lipids in patients at cardiovascular risk. Journal of Cardiovascular Risk, 10(1), 31-40.